Document is current
Any future updates will be listed below
-
Authors
Rowe, Lindsay S. http://orcid.org/0000-0002-7980-0996
Harmon, Stephanie
Horn, Adam
Shankavaram, Uma
Roy, Soumyajit
Ning, Holly
Lindenberg, Liza
Mena, Esther
Citrin, Deborah E.
Choyke, Peter
Turkbey, Baris
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct02190279 at ClinicalTrials.govnct03181867 at ClinicalTrials.govDocuments that mention this clinical trial
Pattern of failure in prostate cancer previously treated with radical prostatectomy and post-operative radiotherapy: a secondary analysis of two prospective studies using novel molecular imaging techniques
https://doi.org/10.1186/s13014-020-01733-x
Documents that mention this clinical trial
Pattern of failure in prostate cancer previously treated with radical prostatectomy and post-operative radiotherapy: a secondary analysis of two prospective studies using novel molecular imaging techniques
https://doi.org/10.1186/s13014-020-01733-x
-
Funding
Funding for this research was provided by:
National Cancer Institute (ZID BC 010990)
- License Information
-
More Information
Article History
Received: 8 July 2020
Accepted: 17 December 2020
First Online: 10 February 2021
Ethics approval and consent to participate
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. Informed consent was obtained from all individual participants included in the study.
: Consent for publication was obtained by each participant.
: BT reports non-financial support from Philips, non-financial support from NVIDIA, other from InVivo Coorperation, outside the submitted work. SR reports grants from Abbvie-Canadian Association of Radiation Oncology Uro-oncologic award (ACURA), Grants from BC Cancer Agency—Radiotherapy Education Process Fund, outside the submitted work. The authors declare that they have no other conflicts of interest.
